Literature DB >> 1391096

Competitive binding assay for quantitative determination of GM1 ganglioside in plasma and cerebrospinal fluid.

G Kirschner1, M Bassan, M P Facco, G Ferrari, L Callegaro.   

Abstract

A competitive binding assay for the quantitative determination of GM1 ganglioside is described. After extraction from biological fluids, GM1 was incubated with a known amount of cholera toxin B-subunit conjugated with horseradish peroxidase, and exposed to GM1 adsorbed onto polystyrene microwells. Since GM1 in solution blocks the binding of toxin B-subunit to GM1 adsorbed onto the solid phase, enzyme activity serves as a reciprocal measure of GM1 concentration in the sample. The assay was used to determine the basal level of GM1 in plasma and cerebrospinal fluid in different populations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391096     DOI: 10.1016/0731-7085(92)80024-h

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Monosialoganglioside GM1 blood levels in maternal and newborn umbilical cord blood at birth.

Authors:  V Zanardo; L Marchesini; G Kirschner
Journal:  Childs Nerv Syst       Date:  1993-12       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.